Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

US Patent 6824793 · Granted Nov 30, 2004

Estimated economic value: $19,949,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adjuvanted vaccines with non-virion antigens prepared from influenza viruses gro2023
Virion-like delivery particles for self-replicating RNA molecules2022
Influenza vaccines with reduced amounts of squalene2022
Oil-in-water emulsions including retinoic acid2021
Cationic oil-in-water emulsions2021
Method for preparing composition comprising a cationic oil-in-water emulsion2021
Oil-in-water emulsions that contain nucleic acids2021
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses gro2020
Adjuvanted formulations of booster vaccines2020
Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration2020
Combination vaccines with lower doses of antigen and/or adjuvant2020
Irradiated biodegradable polymer microparticles2019